5 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Withdrawn 5 |
Follow Puerperal Disorders: new trials by email Literature Review of Puerperal Disorders trials Research Report on Puerperal Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Multimodal Neuroimaging Parameters in Women With Postpartum Depression Who Are Receiving ZULRESSO™ (Brexanolone) Brexanolone - Postpartum Depression | Phase 4 | Withdrawn | Sage Therapeutics | 2020-02-01 | 2020-08-18 | |
| Prevention of Postpartum Hemorrhage With TXA Tranexamic Acid 1000 mg/10ml normal saline infusion - Postpartum Hemorrhage | Phase 4 | Withdrawn | United States Naval Medical Center, San Diego | 2018-04-20 | 2024-01-26 | |
| An Evidence Based Protocol for Oxytocin Administration in Vaginal Delivery Oxytocin - Uterine Atony, Postpartum Hemorrhage | Phase 4 | Withdrawn | NYU Langone Health | 2015-11-01 | 2017-07-31 | |
| PCC and Fibrinogen Compared With FFP in PPH PCC, FFP - Postpartum Haemorrhage | Phase 4 | Withdrawn | Helsinki University Central Hospital | 2013-07-01 | 2018-10-10 | |
| Does Intramyometrial Oxytocin Improve Outcome in Elective Cesarean Delivery? Oxytocin, Saline - Postpartum Hemorrhage, Uterine Atony | Phase 4 | Withdrawn | University of Saskatchewan | 2011-08-01 | 2012-01-11 |
Postpartum Hemorrhage (4) · Uterine Inertia (2) · Depression, Postpartum (1) · Hemorrhage (1)
Female Urogenital Diseases and Pregnancy Complications (5) · Pregnancy Complications (5) · Urogenital Diseases (5) · Obstetric Labor Complications (4) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Uterine Hemorrhage (4) · Hemorrhage (3) · Dystocia (2) · Depressive Disorder (1) · Mental Disorders (1) · Mood Disorders (1)
Oxytocin (2) · Sodium Chloride (1) · Tranexamic Acid (1) · brexanolone (1) · prothrombin complex concentrates (1)
Helsinki University Central Hospital (1) · NYU Langone Health (1) · Sage Therapeutics (1) · United States Naval Medical Center, San Diego (1) · University of Saskatchewan (1)
Canada (1) · Finland (1) · United States (1)
David C Campbell, MD, FRCPC (1) · Jade King, BS (1) · Jouni V. Ahonen, Ph.D., M.D. (1) · Kevin Fitzpatrick, MD (1) · Maureen E Farrell, MD (1) · Monica K San Vicente, MD (1) · Roulhac D Toledano, MD, PhD (1) · Violetta Lozovyy, MD (1)
PMID 20554319, PMID 25571934, PMID 26079202, PMID 26118386, PMID 26226243, PMID 26698831, PMID 26952346, PMID 27558956, PMID 28456509